U.S. probing two new blood clot cases after J&J’s COVID-19 vaccine

0
FILE PHOTO: Vials with a sticker reading, “COVID-19 / Coronavirus vaccine / Injection only” and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/File Photo

(Reuters) – Two new cases of blood clots after administration of Johnson & Johnson’s single-dose COVID-19 vaccine are being investigated by federal health officials, the U.S. Centers for Disease Control and Prevention said on Tuesday.

One case was in a male and the other was in a female, both of whom were below 60 years, according to the agency, taking the total number of confirmed such cases to 17 out of 8 million shots given.

The new cases come after U.S. health regulators on Friday recommended resumption of use of J&J’s shot, ending a 10-day pause to investigate its link to extremely rare but potentially deadly blood clots.

- ADVERTISEMENT -

The CDC and the Food and Drug Administration said on Friday the risks of experiencing the syndrome involving severe blood clots and low platelets as a result of the vaccine were very low.

(Reporting by Ankur Banerjee and Manojna Maddipatla in Bengaluru; Editing by Shailesh Kuber)

Share

LEAVE A REPLY

Please enter your comment!
Please enter your name here


By submitting this form, you are consenting to receive marketing emails from: News India Times | Desi Talk Headlines | Desi Talk Chicago, 35 JOURNAL SQ, JERSEY CITY, NJ, 07306, http://www.newsindiatimes.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact